Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 25, 2017

DrugPatentWatch Database Preview

Meloxicam - Generic Drug Details

« Back to Dashboard

What are the generic sources for meloxicam and what is the scope of patent protection?

Meloxicam
is the generic ingredient in three branded drugs marketed by Taro, Aurobindo Pharma, Yung Shin Pharm, Breckenridge Pharm, Zydus Pharms Usa, Mylan, Roxane, Unichem, Strides Pharma, Cipla Ltd, Boehringer Ingelheim, Corepharma, Dr Reddys Labs Inc, Glenmark Generics, Iroko Pharms Llc, Yabao Pharm, Frontida Biopharm, Teva Pharms, Sun Pharm Inds Inc, Puracap Pharm, Cr Double Crane, Lupin Pharms, and Apotex Inc, and is included in twenty-five NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Meloxicam has thirty-seven patent family members in twenty-eight countries.

There are twenty-two drug master file entries for meloxicam. Fifty-six suppliers are listed for this compound.

Summary for Generic Name: meloxicam

Tradenames:3
Patents:3
Applicants:23
NDAs:25
Drug Master File Entries: see list22
Suppliers / Packagers: see list56
Bulk Api Vendors: see list86
Clinical Trials: see list10
Patent Applications: see list8,038
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:meloxicam at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
MELOXICAM
meloxicam
TABLET;ORAL077882-002Jul 20, 2006ABRXNoNo► Subscribe► Subscribe
Iroko Pharms Llc
VIVLODEX
meloxicam
CAPSULE;ORAL207233-002Oct 22, 2015RXYesYes► Subscribe► Subscribe
Glenmark Generics
MELOXICAM
meloxicam
TABLET;ORAL077932-001Jul 19, 2006ABRXNoNo► Subscribe► Subscribe
Roxane
MELOXICAM
meloxicam
TABLET;ORAL077925-001Jul 19, 2006DISCNNoNo► Subscribe► Subscribe
Breckenridge Pharm
MELOXICAM
meloxicam
TABLET;ORAL077920-001Jul 19, 2006ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot